Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2008-01-22
2008-01-22
Moran, Marjorie A. (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C702S027000, C536S023100, C435S006120
Reexamination Certificate
active
09960706
ABSTRACT:
The present invention relates to a computer system comprising a database for elucidating changes in gene expression in prostate tissue isolated from patients exhibiting different clinical states of prostate hyperplasia as compared to normal prostate tissue, as well as the identification of individual genes that are differentially expressed in diseased prostate tissue.
REFERENCES:
patent: 5763429 (1998-06-01), Bishop et al.
patent: 5882864 (1999-03-01), An et al.
patent: 5953727 (1999-09-01), Maslyn et al.
patent: 2003/0134324 (2003-07-01), Munger et al.
NCBI accession No. N30198. Jan. 5, 1996.
NCBI accession No. R93908. Aug. 30, 1995.
NCBI accession No. S77622. May 7, 1993.
Hillier et al. Accession No. AA410383, May 17, 1997, record retrieved from www.ncbi.nlm.nih.gov.
Elsasser-Beile et al., Comparison of the Activation Status of Tumor Infiltrating and Peripheral Lymphocytes of Patients with Adenocarcinomas and Benign Hyperplasia of the Prostate, (2000) The Prostate, 45:1-7.
Shidaifat et al., Gossypol Arrests Human Benign Prostatic Hyperplastic Cell Growth at G0/G1 Phase of the Cell Cycle, (1997) Anticancer Res. 17:1003-1010.
Bubendorf, L et al. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. (1999) Cancer Research 59:803-806.
Bubendorf, L et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. (1999) J. Nat. Cancer Inst. 91(20):1758-1764.
Brinkman, U. et al. Page-1 an X Chromosome-Linked Gage-Like Gene That is Expressed in Normal and Neoplastic Prostate, Testis, and Uterus (1998)Proc. Natl. Acad. Sci. (USA) 96:20767-20762.
Brinkman, U. et al. Novel Genes in the Page and Gage Family of Tumor Antigens Found by Homology Walking in the dbEST Database. (1999)Cancer Res. 59, 1445-148.
Isomura, M. et al. Isolation and Mapping of RAB2L, a Human cDNA That Encodes a Protein Homologous to RalGDS. (1996)Cyogenet.Cell Genet. 74, 263-265.
Jacob, K. et al. Osteonectin Promotes Prostate Cancer Cell Migration and Invasion: a Possible Mechanism for Metastasis to Bone (1999)Cancer Res. 59:4453-4457.
Nollet, F. et al. Phylogenetic Analysis of the Cadherin Superfamily Allows Identifidation of Six Major Subfamilies Besides Several Solitary Members (2000)J. Mol. Bio. 299, 51-572.
Seto, M.H. et al. Pro Fold Analysis of the B30.2-Like Domain (1999)Proteins35:235-49.
Thomas, R. et al. Differential Expresison of Osteonectin/SPARC During Human Prostate Cancer Progression (2000)Clin. Cancer Res. 6:1140-1149.
Getzenberg Robert H.
Kulkarni Prakash
Munger William E.
Waga Iwao
Yamamoto Jun
Gene Logic Inc.
Moran Marjorie A.
Morgan & Lewis & Bockius, LLP
University of Pittsburgh
LandOfFree
Identifying drugs for and diagnosis of benign prostatic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identifying drugs for and diagnosis of benign prostatic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identifying drugs for and diagnosis of benign prostatic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3953905